TWINNING FOR A EUROPEAN CONSORTIUM OF RECTAL CANCER RESEARCH INSTITUTIONS THROUGH STEPPING UP SCIENTIFIC, TECHNOLOGICAL AND INNOVATION EXCELLENCE OF IORS

Informazioni relative al progetto

STEPUPIORS

ID dell’accordo di sovvenzione: 101079217

DOI

10.3030/101079217

Progetto chiuso

Data della firma CE 14 Luglio 2022

Data di avvio 1 Ottobre 2022

Data di completamento 30 Settembre 2025

Finanziato da

• Widening participation and spreading excellence

Costo totale

€ 1 500 000,00

Contributo UE

€ 1 500 000,00

Coordinato da

INSTITUT ZA ONKOLOGIJU I RADIOLOGIJU SRBIJE
Serbia

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (2)

Midterm report of staff exchanges, expert visits to IORS and research proposals submitted

Research and administrative staff exchanges (IORS and BRFAA - in collaboration with IDIBAPS and NKI) Expert visits to IORS (BRFAA, IDIBAPS and NKI, one visit each)Remote virtual training on omics data analysis (BRFAA, IDIBAPS and NKI - expertise applied to IORS staff)Preparation and submission of research proposals with emphasis on MSCA doctoral networks and postdoctoral fellowships (BRFAA, IDIBAPS and NKI AVL - expertise applied to IORS staff)

Increased IORS human capacities for biobank management and oversight

1.4 Train IORS personnel for biobank management and oversight (IDIBAPS/HCB and NKI)

Demonstrators, pilots, prototypes (1)

Establishment of a Research Management office at IORS

Form a Research Management Office at IORS by training IORS staff in specific management procedures and protocols (IORS - with expert advice from BRFAA, IDIBAPS/HCB and NKI)Train IORS staff on pre- and post-grant project management activities

Pubblicazioni

Thesis and dissertations (1)

Ispitivanje prognostičkih i prediktivnih kliničkih i molekularnih markera u lečenju lokalno uznapredovalog karcinoma rektuma neoadjuvantnom radiohemioterapijom primenom volumnog rotacionog planiranja zračne terapije i simultanog integrisanog boost-a

Autori: Marinkovic Mladen
Pubblicato in: 2024
Editore: Faculty of Medicine, University of Belgrade

Peer reviewed articles (8)

Abstracts

Pubblicato in: Molecular Oncology, Numero 19, 2025, ISSN 1574-7891
Editore: Wiley
DOI: 10.1002/1878-0261.70070

Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy

Autori: Stanojevic A, Spasic J, Marinkovic M, Stojanovic-Rundic S, Jankovic R, Djuric A, Zoidakis J, Fijneman R.J.A, Castellvi-Bel S, Cavic M.
Pubblicato in: Frontier in Genetics, Numero 14, 2024, ISSN 1664-8021
Editore: Frontiers
DOI: 10.1101/2023.09.21.23295916

Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Autori: Marinkovic M, Stojanovic-Rundic S, Stanojevic A, Ostojic M, Gavrilovic D, Jankovic R, Maksimovic N, Stroggilos R, Zoidakis J, Castellví-Bel S, Fijneman RJA, Cavic M.
Pubblicato in: Frontier in Genetics, Numero 14, 2023, ISSN 1664-8021
Editore: Frontiers Media S.A.
DOI: 10.1101/2023.06.20.23291673

Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer

Autori: Vuletic A, Mirjacic Martinovic K, Spasic J.
Pubblicato in: Pharmaceutics, Numero 16(1):54, 2023, ISSN 1999-4923
Editore: MDPI (Basel, Switzerland)
DOI: 10.20944/preprints202311.1805.v1

Performance and Dimensionality of Pretreatment MRI Radiomics in Rectal Carcinoma Chemoradiotherapy Prediction

Autori: Marinković, M.; Stojanović-Rundić, S.; Stanojevic, A.; Tomašević, A.; Janković, R.; Zoidakis, J.; Castellví-Bel, S.; Fijneman, R.J.; Čavić, M.; Radulović, M
Pubblicato in: Journal of Clinical Medicine, Numero 13(2):421, 2024, ISSN 2077-0383
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.20944/preprints202310.0560.v1

Data-Independent Acquisition Mass Spectrometry Analysis of FFPE Rectal Cancer Samples Offers In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy

Autori: Stanojevic A, Samiotaki M, Lygirou V, Marinkovic M, Nikolic V, Stojanovic-Rundic S, Jankovic R, Vlahou A, Panayotou G, Fijneman RJA, Castellví-Bel S, Zoidakis J, Cavic M
Pubblicato in: Int J Mol Sci, Numero 24(20), 2023, ISSN 1661-6596
Editore: MDPI (Basel, Switzerland)
DOI: 10.1101/2023.05.12.23289671

Precision public health perspective: Is genomic population screening a viable option for the early detection of risks for oncological diseases? Reflections from Serbia

Autori: Bosiljka Đikanović, Janko Janković, Milena Čavić
Pubblicato in: Srpski medicinski casopis Lekarske komore, Numero 6, 2025, ISSN 2737-971X
Editore: Centre for Evaluation in Education and Science (CEON/CEES)
DOI: 10.5937/smclk6-57145

Dose Escalation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Short-Term Efficacy and Toxicity of VMAT–SIB vs. 3D-CRT

Autori: Suzana Stojanovic-Rundic, Mladen Marinkovic, Aleksandra Stanojevic, Dusica Gavrilovic, Radmila Jankovic, Natasa Maksimovic, Aleksandar Tomasevic, Predrag Petrasinovic, Sandra Radenkovic, Milena Cavic
Pubblicato in: Medicina, Numero 61, 2025, ISSN 1648-9144
Editore: MDPI AG
DOI: 10.3390/MEDICINA61030483

Conference proceedings (5)

The Road from Human Sample Collections to the First Rectal Cancer Biobank at the Institute for Oncology and Radiology of Serbia

Autori: A. Djuric, M. Tanic, S. Bjelogrlic, S. StojanovicRundic, M. Marinkovic, A. Stanojevic, R. Fijenman, S. Castellví-Bel, J. Zoidakis, M. Cavic
Pubblicato in: Molecular Oncology, Numero 17 (Suppl. 1) (2023) 1–597. p464-465, 2023, ISSN 1574-7891
Editore: John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies
DOI: 10.1002/1878-0261.13469

Cancer Research

Autori: Cavic M, Djuric A, Marinkovic M, Stanojevic A, Tanic M, Bjelogrlic S, Spasic J, Damjanovic A, Djordjic Crnogorac M, Vuletic A, Mirjacic Martinovic K, Radulovic M, Stojanovic-Rundic S, Krivokuca A, Jankovic R, Castellvi-Bel S, Zoidakis J, Fijneman R.
Pubblicato in: Cancer Research, Numero 84 (6_Supplement): 1304, 2024, ISSN 0008-5472
Editore: American Association for Cancer Research

Molecular Oncology

Autori: Djuric A, Radulovic M, Damjanovic A, Fijneman R, Castellvi-Bel S, Zoidakis J, Cavic M.
Pubblicato in: Molecular Oncology, Numero Vol. 18. Supp. 1, 2024, ISSN 1574-7891
Editore: Elsevier BV
DOI: 10.1002/1878-0261.13683

Molecular Oncology

Autori: Vuletic A, Mirjačić Martinović K, Srdić-Rajić T, Tišma Miletić N, Đurić A, Nikolić K, Ružić D, Čavić M.
Pubblicato in: Molecular Oncology, Numero 19 (S1), 2025, ISSN 1574-7891
Editore: Elsevier BV

Correlation between genetic and proteomic expression of predictive biomarkers of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer identified by DIA mass spectrometry

Autori: A. Stefanovic, V. Lygirou, S. Stojanović-Rundić, R. Janković, S. Castellvi-Bel, R. J.A. Fijneman, A. Vlahou, J. Zoidakis, M. Samiotaki, M. Čavić
Pubblicato in: Molecular Oncology, Numero 17 (Suppl. 1) (2023) 1–597. p96-97, 2023, ISSN 1574-7891
Editore: John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies
DOI: 10.1002/1878-0261.13469